8-K
Current Report
Niagen Bioscience, Inc. Filed Acc 0001415889-12-001062
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading cdx8k_july132012.htm…